American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination pentostatin and cyclophosphamide: Complete responses without severe myelosuppression in previously treated patients with CLL
    Meeting Abstract

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
    Blood (2000)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory Hodgkin's disease (HD) treated with high dose chemoradiotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hedrick, E. E.; Gonzalez, M.; Yahalom, J.
    Blood (2000)

    Fulltext@MSK | Save
  • Outcome of adult patients (pts) with chemosensitive (CS) relapsed or primary refractory Hodgkin's disease (HD) or aggressive NHL (NHL) after failure of autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Malhotra, S.; Qin, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2000)

    Fulltext@MSK | Save
  • Role of p65(dok) in leukemogenesis by p210(bcr-abl)
    Meeting Abstract

    Niki, M.; Di Cristofano, A.; Zhao, M.; Karnell, F. G.; Clarkson, B.; Pear, W. S.; Van Aelst, L.; Pandolfi, P. P.
    Blood (2000)

    Fulltext@MSK | Save
  • Synthetic analogue bcr/abl fusion peptides improve class I immunogenicity to the native protein
    Meeting Abstract

    Pinilla-Ibarz, J.; Korontvitz, T.; Roberts, W.; Shaed, S.; Cathcart, K.; Scheinberg, D. A.
    Blood (2000)

    Fulltext@MSK | Save
  • Noninvasive imaging of human radiolabeled antigen-specific donor T lymphocytes after adoptive immunotherapy in SCID mice
    Meeting Abstract

    Koehne, G.; Zanzonico, P.; Gallardo, H. F.; May, C.; Balatoni, J.; Riviere, I.; O'Reilly, R. J.; Sadelain, M.; Larson, S. M.
    Blood (2000)

    Fulltext@MSK | Save
  • Transplantation of bone marrow derived VEGF-responsive hematopoietic and vasculogenic precursor cells are essential to restore the angiogenic defect in Id1+/-Id3-/- knock out mice
    Meeting Abstract

    Lyden, D.; Hattori, K.; Dias, S.; Hajjar, K.; Manova, K.; Moore, M. A. S.; Benezra, R.; Rafii, S.
    Blood (2000)

    Fulltext@MSK | Save
  • In vivo inhibition of matrix metalloproteinases blocks chemo-cytokine induced endothelial and hematopoietic stem cell mobilization
    Meeting Abstract

    Heissig, B.; Hattori, K.; Dias, S.; Crystal, R. G.; Wood, J.; Moore, M. A. S.; Rafii, S.
    Blood (2000)

    Fulltext@MSK | Save
  • Controlled graft-versus-leukemia reaction after adoptive transfer of HSV-TK modified allogeneic donor T lymphocytes sensitized with B7.1 transduced ALL cells
    Meeting Abstract

    Koehne, G.; Gallardo, H. F.; Latouche, J. B.; May, C.; Steinherz, P.; Heller, G.; Sadelain, M.; O'Reilly, R. J.
    Blood (2000)

    Fulltext@MSK | Save
  • Role of Daxx in B cell selection and apoptosis by CD40
    Meeting Abstract

    Salomoni, P.; Pandolfi, P. P.
    Blood (2000)

    Fulltext@MSK | Save